Tiaozhan Zheng
Overview
Explore the profile of Tiaozhan Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He D, Lu H, Ou X, Zheng T, Zheng Z, Xu Z, et al.
BMC Cancer
. 2025 Jan;
25(1):152.
PMID: 39871145
Objective: This study seeks to elucidate the causal relationship between major coronary heart disease events (MCHDE) and lung cancer incidence through mendelian randomization (MR), with the goal of providing evidence...
2.
Deng K, Yuan L, Xu Z, Qin F, Zheng Z, Huang L, et al.
PeerJ
. 2024 Aug;
12:e17816.
PMID: 39193519
Background: Lymphocyte antigen 9 (LY9) participates in the development of several tumors and diseases but has not been reported yet in lung adenocarcinoma (LUAD). Methods: First, we analyzed the expression...
3.
Xu Z, He D, Huang L, Deng K, Jiang W, Qin J, et al.
J Cell Mol Med
. 2024 Jun;
28(11):e18406.
PMID: 38822457
Increasing evidence has shown that homologous recombination (HR) and metabolic reprogramming are essential for cellular homeostasis. These two processes are independent as well as closely intertwined. Nevertheless, they have rarely...
4.
Zheng T, Zheng Z, Zhou H, Guo Y, Li S
Comput Biol Med
. 2024 Jan;
170:107896.
PMID: 38217972
Background: Abnormal expression of collagen IV subunits has been reported in cancers, but the significance is not clear. No study has reported the significance of COL4A4 in lung adenocarcinoma (LUAD)....
5.
Jiang W, Xu Z, Huang L, Qin F, Yuan L, Sun Y, et al.
BMC Med Genomics
. 2023 Dec;
16(1):330.
PMID: 38110999
Objective: To explore the metabolism-related lncRNAs in the tumorigenesis of lung adenocarcinoma. Methods: The transcriptome data and clinical information about lung adenocarcinoma patients were acquired in TCGA (The Cancer Genome...
6.
Xu Z, Zheng T, Zheng Z, Jiang W, Huang L, Deng K, et al.
Front Immunol
. 2023 Sep;
14:1224340.
PMID: 37744350
Background: T-cell Activation GTPase Activating Protein (TAGAP) plays a role in immune cell regulation. This study aimed to investigate TAGAP's expression and its potential impact on CD4+ T cell function...
7.
Zheng T, Zhou H, Zheng Z, Guo Y, Liu J, Zhang J, et al.
Comput Biol Med
. 2023 Apr;
158:106894.
PMID: 37058762
Background: Emerging evidences suggest that ARHGEF6 is involved in cancers but the exact significance and underlying mechanism are unclear. This study aimed to elucidate the pathological significance and potential mechanism...
8.
Deng K, Lin S, Xu Z, Qin J, Yuan L, Sun Y, et al.
Medicine (Baltimore)
. 2022 Oct;
101(41):e30982.
PMID: 36254009
The highly malignant nature of lung adenocarcinoma (LUAD) makes its early diagnosis and prognostic assessment particularly important. However, whether the CXC subfamily of chemokine receptors (CXCR) is involved in the...
9.
Qin F, Sun Y, Deng K, Qin J, Xu Z, Wei J, et al.
Life Sci
. 2022 Mar;
297:120492.
PMID: 35337671
No abstract available.
10.
Qin F, Lin S, Deng K, Qin J, Xu Z, Yuan L, et al.
World J Surg Oncol
. 2021 Sep;
19(1):275.
PMID: 34521431
Background: Squamous cell carcinoma (SCC) is a disease with distinct management complexities as it displays a remarkably heterogeneous molecular subtype. However, the landscape of angiogenesis for SCC is not fully...